Reuters logo
10 months ago
BRIEF-Coherus says completes two pharmacokinetic bioequivalence studies of CHS-0214
October 6, 2016 / 8:21 PM / 10 months ago

BRIEF-Coherus says completes two pharmacokinetic bioequivalence studies of CHS-0214

1 Min Read

Oct 6 (Reuters) - Coherus Biosciences

* Says completes two pharmacokinetic bioequivalence studies of CHS-0214

* Moving forward with pre-submission meetings, now expected in Q1 2017, to review complete CHS-0214 program prior to filing

* CHS-0214-06 study achieved primary PK BE endpoint Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below